Results 31 to 40 of about 13,793 (230)

Prevalence of minimal hepatic encephalopathy in cirrhotic patients

open access: yesAnnals of Hepatology, 2011
Background. Minimal hepatic encephalopathy (MHE) has implications for health-related quality of life as well as for survival of cirrhotic patients, but a standardized diagnostic test is not available.Objective.
Héctor Jesús Maldonado-Garza   +5 more
doaj   +3 more sources

The role of multifocal visual evoked potential in detection of minimal hepatic encephalopathy in patients with compensated liver cirrhosis [PDF]

open access: yesBMC Neurology
Background Minimal hepatic encephalopathy (MHE) is one of the most debilitating complications of hepatic cirrhosis, and visual electrophysiology, visual evoked potential (VEP) has long been used for MHE diagnosis.
Reem M. Sabry   +5 more
doaj   +2 more sources

Minimal hepatic encephalopathy in patients with cirrhosis by measuring liver stiffness and hepatic venous pressure gradient

open access: yesThe Saudi Journal of Gastroenterology, 2012
Background/Aim : Transient elastography (TE) of liver and hepatic venous pressure gradient (HVPG) allows accurate prediction of cirrhosis and its complications in patients with chronic liver disease.
Praveen Sharma, Ashish Kumar
doaj   +2 more sources

The Prevalence of Minimal Hepatic Encephalopathy in an Outpatient Hepatology Clinic. [PDF]

open access: yesTurk J Gastroenterol, 2023
Eyice D   +8 more
europepmc   +2 more sources

Hepatic Encephalopathy [PDF]

open access: yes, 2023
Hepatic encephalopathy (HE) is a complex neurological syndrome, characteristic of patients with liver disease, that causes a wide and complex spectrum of nonspecific neurological and psychiatric manifestations, ranging from a subclinical entity such as ...

core   +1 more source

Contemporary management of pain in cirrhosis: Toward precision therapy for pain

open access: yesHepatology, EarlyView., 2022
Abstract Chronic pain is highly prevalent in patients with cirrhosis and is associated with poor health‐related quality of life and poor functional status. However, there is limited guidance on appropriate pain management in this population, and pharmacologic treatment can be harmful, leading to adverse outcomes, such as gastrointestinal bleeding ...
Alexis Holman   +4 more
wiley   +1 more source

Circulating TREM2 as a noninvasive diagnostic biomarker for NASH in patients with elevated liver stiffness

open access: yesHepatology, EarlyView., 2022
Abstract Background and Aims Reliable noninvasive biomarkers are an unmet clinical need for the diagnosis of NASH. This study investigates the diagnostic accuracy of the circulating triggering receptor expressed on myeloid cells 2 (plasma TREM2) as a biomarker for NASH in patients with NAFLD and elevated liver stiffness.
Vineesh Indira Chandran   +17 more
wiley   +1 more source

Minimal Hepatic Encephalopathy

open access: yes, 2021
Preregistration of the protocol for a scoping review investigating neuroimaging biomarkers of minimal hepatic ...
Hannah Windmill, Sandra Olmesdahl
core   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

open access: yes, 2022
Hepatology, EarlyView.
Robert J. Fontana   +6 more
wiley   +1 more source

Resting state cortical electroencephalographic rhythms in covert hepatic encephalopathy and Alzheimer's disease [PDF]

open access: yes, 2013
Patients suffering from prodromal (i.e., amnestic mild cognitive impairment, aMCI) and overt Alzheimer's disease (AD) show abnormal cortical sources of resting state electroencephalographic (EEG) rhythms.
Nicola Marzano   +50 more
core   +1 more source

Home - About - Disclaimer - Privacy